Endocrinology, Vol 124, 1539-1547, Copyright © 1989 by Endocrine Society

ARTICLES

Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix

RK Globus, J Plouet and D Gospodarowicz
Cancer Research Institute, University of California Medical Center, San Francisco 94143.

Bone contains various growth factors, including fibroblast growth factor (FGF). The cellular origins of the growth factors found in bone are not known. We examined whether cultured fetal bovine bone cells synthesize FGF. These cells express characteristic markers of the osteoblast phenotype, including expression of bone Gla protein (osteocalcin) and mineralization. Heparin-Sepharose fractionation of cell extracts revealed that bone cells contained a basic FGF (bFGF)- like molecule, that displayed high affinity for heparin. The growth factor was mitogenic for adrenal cortex-derived endothelial cells and osteoblast-like bone cells. The major peak of biological activity corresponded to a peak of immunoreactive bFGF. When analyzed by Western blot, the active fractions contained a bFGF-like immunoreactive species with a mol wt of 15,000, a mass identical to that of (des-1-15)bFGF. Based on RIA, the bone cell extract contained an estimated 95 ng bFGF/mg cell protein. An acidic FGF-like molecule with lower affinity for heparin was also present in the purified bone cell extracts, although at an approximately 10-fold lower concentration than bFGF. These results demonstrate that bone cells synthesize a mitogen indistinguishable from bFGF. In addition, Northern analysis revealed that the bone cells expressed 3.5- and 7.0-kilobase bFGF gene transcripts. We next examined whether the bone cell-derived bFGF is stored in a bioactive form in the extracellular matrix. Bone cells synthesized an extracellular matrix which was mitogenic for adrenal cortex-derived endothelial cells. However, if the bone cell extracellular matrix was preincubated with neutralizing anti-bFGF antibodies, its mitogenic properties were abolished. This suggests that bone cell-derived bFGF may function as an autocrine or paracrine mitogen via its deposition into the extracellular matrix of bone.

This article has been cited by other articles:

				F. C. CACKOWSKI and G. D. ROODMAN Perspective on the Osteoclast: An Angiogenic Cell? Ann. N.Y. Acad. Sci., November 1, 2007; 1117(1): 12 - 25. [Abstract] [Full Text] [PDF]

				D. J. HADJIDAKIS and I. I. ANDROULAKIS Bone Remodeling Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 385 - 396. [Abstract] [Full Text] [PDF]

				M. P. Valta, T. Hentunen, Q. Qu, E. M. Valve, A. Harjula, J. A. Seppanen, H. K. Vaananen, and P. L. Harkonen Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8 Endocrinology, May 1, 2006; 147(5): 2171 - 2182. [Abstract] [Full Text] [PDF]

				N. S. Tumia and A. J. Johnstone Promoting the Proliferative and Synthetic Activity of Knee Meniscal Fibrochondrocytes Using Basic Fibroblast Growth Factor In Vitro Am. J. Sports Med., June 1, 2004; 32(4): 915 - 920. [Abstract] [Full Text] [PDF]

				Y. Okada, A. Montero, X. Zhang, T. Sobue, J. Lorenzo, T. Doetschman, J. D. Coffin, and M. M. Hurley Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone J. Biol. Chem., May 30, 2003; 278(23): 21258 - 21266. [Abstract] [Full Text] [PDF]

				H.-J. Kim, J.-H. Kim, S.-C. Bae, J.-Y. Choi, H.-J. Kim, and H.-M. Ryoo The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2 J. Biol. Chem., January 3, 2003; 278(1): 319 - 326. [Abstract] [Full Text] [PDF]

				G. Xiao, D. Jiang, R. Gopalakrishnan, and R. T. Franceschi Fibroblast Growth Factor 2 Induction of the Osteocalcin Gene Requires MAPK Activity and Phosphorylation of the Osteoblast Transcription Factor, Cbfa1/Runx2 J. Biol. Chem., September 20, 2002; 277(39): 36181 - 36187. [Abstract] [Full Text] [PDF]

				G. Barillari and B. Ensoli Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma Clin. Microbiol. Rev., April 1, 2002; 15(2): 310 - 326. [Abstract] [Full Text] [PDF]

				S. R. Rittling, Y. Chen, F. Feng, and Y. Wu Tumor-derived Osteopontin Is Soluble, Not Matrix Associated J. Biol. Chem., March 8, 2002; 277(11): 9175 - 9182. [Abstract] [Full Text] [PDF]

				E. A. Nauman, R. L. Satcher, T. M. Keaveny, B. P. Halloran, and D. D. Bikle Osteoblasts respond to pulsatile fluid flow with short-term increases in PGE2 but no change in mineralization J Appl Physiol, May 1, 2001; 90(5): 1849 - 1854. [Abstract] [Full Text] [PDF]

				H. Kawaguchi, K. Nakamura, Y. Tabata, Y. Ikada, I. Aoyama, J. Anzai, T. Nakamura, Y. Hiyama, and M. Tamura Acceleration of Fracture Healing in Nonhuman Primates by Fibroblast Growth Factor-2 J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 875 - 880. [Abstract] [Full Text]

				A. Iwakura, Y. Tabata, K. Nishimura, T. Nakamura, Y. Shimizu, M. Fujita, and M. Komeda Basic fibroblast growth factor may improve devascularized sternal healing Ann. Thorac. Surg., September 1, 2000; 70(3): 824 - 828. [Abstract] [Full Text] [PDF]

				Md. Muniruzzaman, Y. Tabata, and Y. Ikada Physicochemical Properties of Basic Fibroblast Growth Factor-Gelatin Complex Journal of Bioactive and Compatible Polymers, September 1, 2000; 15(5): 365 - 375. [Abstract] [PDF]

				S. Varghese, S. Rydziel, and E. Canalis Basic Fibroblast Growth Factor Stimulates Collagenase-3 Promoter Activity in Osteoblasts through an Activator Protein-1-Binding Site Endocrinology, June 1, 2000; 141(6): 2185 - 2191. [Abstract] [Full Text] [PDF]

				H. Liang, S. Pun, and T. J. Wronski Bone Anabolic Effects of Basic Fibroblast Growth Factor in Ovariectomized Rats Endocrinology, December 1, 1999; 140(12): 5780 - 5788. [Abstract] [Full Text]

				N. Manabe, H. Oda, K. Nakamura, Y. Kuga, S. Uchida, and H. Kawaguchi Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients Rheumatology, August 1, 1999; 38(8): 714 - 720. [Abstract] [Full Text] [PDF]

				M. G. Sabbieti, L. Marchetti, C. Abreu, A. Montero, A. R. Hand, L. G. Raisz, and M. M. Hurley Prostaglandins Regulate the Expression of Fibroblast Growth Factor-2 in Bone Endocrinology, January 1, 1999; 140(1): 434 - 444. [Abstract] [Full Text]

				A. M. Delany and E. Canalis Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in Murine Osteoblasts J. Biol. Chem., June 26, 1998; 273(26): 16595 - 16600. [Abstract] [Full Text] [PDF]

				A. M. Delany and E. Canalis Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts Am J Physiol Cell Physiol, March 1, 1998; 274(3): C734 - C740. [Abstract] [Full Text] [PDF]

				R. Globus, S. Doty, J. Lull, E Holmuhamedov, M. Humphries, and C. Damsky Fibronectin is a survival factor for differentiated osteoblasts J. Cell Sci., January 5, 1998; 111(10): 1385 - 1393. [Abstract] [PDF]

				P. A. Hill, A. Tumber, and M. C. Meikle Multiple Extracellular Signals Promote Osteoblast Survival and Apoptosis Endocrinology, September 1, 1997; 138(9): 3849 - 3858. [Abstract] [Full Text] [PDF]

				D. S. Wang, M. Miura, H. Demura, and K. Sato Anabolic Effects of 1,25-Dihydroxyvitamin D3 on Osteoblasts Are Enhanced by Vascular Endothelial Growth Factor Produced by Osteoblasts and by Growth Factors Produced by Endothelial Cells Endocrinology, July 1, 1997; 138(7): 2953 - 2962. [Abstract] [Full Text] [PDF]

				A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin Biological Roles of Fibroblast Growth Factor-2 Endocr. Rev., February 1, 1997; 18(1): 26 - 45. [Abstract] [Full Text]

				A. Moursi, R. Globus, and C. Damsky Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro J. Cell Sci., January 9, 1997; 110(18): 2187 - 2196. [Abstract] [PDF]

				E. J. Feres-Filho, G. B. Menassa, and P. C. Trackman Regulation of Lysyl Oxidase by Basic Fibroblast Growth Factor in Osteoblastic MC3T3-E1 Cells J. Biol. Chem., March 15, 1996; 271(11): 6411 - 6416. [Abstract] [Full Text] [PDF]

				A. Moursi, C. Damsky, J Lull, D Zimmerman, S. Doty, S Aota, and R. Globus Fibronectin regulates calvarial osteoblast differentiation J. Cell Sci., January 6, 1996; 109(6): 1369 - 1380. [Abstract] [PDF]

				D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, K. Nakamura, and H. Kawaguchi Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase J. Biol. Chem., September 29, 2000; 275(40): 31444 - 31450. [Abstract] [Full Text] [PDF]